GLP1R and Alzheimer disease: Furthermore, selective blocking of Aβ-induced microglial activation via glucagon-like peptide-1 receptor (GLP-1R) activation inhibits formation of reactive astrocytes and preserves neuronal viability in AD models (Park et al., 2021).